Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats

World Journal of Gastroenterology

Volumn 11, Issue 5, 2005, Pages 752-755

  Wu, Zhi Yong ^a   Chen, Xue Song ^a   Qiu, Jiang Feng ^a   Cao, Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hyperdynamic circulatory; Nitric oxide; Portal hypertension; Prostacyclin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARGININE; CARBON TETRACHLORIDE; HEPARIN; INDOMETACIN; NITRATE; NITRIC OXIDE; NITRITE; PROSTACYCLIN; RADIOACTIVE MICROSPHERE; SODIUM CHLORIDE; ANTICOAGULANT AGENT; ENZYME INHIBITOR; N(G) NITROARGININE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART INDEX; HEMODYNAMICS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN OBSTRUCTION; RADIOIMMUNOASSAY; RAT; SPLANCHNIC BLOOD FLOW; STATISTICAL ANALYSIS; VASCULAR RESISTANCE; ANIMAL; BLOOD; DRUG EFFECT; PHYSIOLOGY; PORTAL VEIN; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICOAGULANTS; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; EPOPROSTENOL; HEPARIN; HYPERTENSION, PORTAL; INDOMETHACIN; MALE; NITRIC OXIDE; NITROARGININE; PORTAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SPLANCHNIC CIRCULATION;

EID: 13544277079     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i5.752     Document Type: Article

References (17)

1. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996; 25: 370-378
2. Casadevall M, Panes J, Pique JM, Marroni N, Bosch J, Whittle BJ. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology 1993; 18: 628-634
3. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 1993; 18: 621-627
4. Blanchart A, Hernando N, Fernandez-Munoz D, Hernando L, Lopez-Novoa JM. Lack of effect of indomethacin on systemic and splanchnic haemodynamics in portal hypertensive rats. Clin Sci 1985; 68: 605-607
5. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 1981; 240: G371-G375
6. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology 1993; 18: 1416-1421
7. Pizcueta MP, Pique JM, Bosch J, Whittle BJ, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184-190
8. Guarner C, Soriano G, Such J, Teixido M, Ramis I, Bulbena O, Rosello J, Guarner F, Gelpi E, Balanzo J. Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. Gastroenterology 1992; 102: 303-309
9. Hamilton G, Phing RC, Hutton RA, Dandona P, Hobbs KE. The relationship between prostacyclin activity and pressure in the portal vein. Hepatology 1982; 2: 236-242
10. Sitzmann JV, Campbell K, Wu Y, St Clair C. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension. Surgery 1994; 115: 290-294
11. Hou MC, Cahill PA, Zhang S, Wang YN, Hendrickson RJ, Redmond EM, Sitzmann JV. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation. Hepatology 1998; 27: 20-27
12. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A 2000; 97: 9747-9752
13. Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, Chemtob S. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res 1998; 83: 721-729
14. Nakamura H, Kim DK, Philbin DM, Peterson MB, Debros F, Koski G, Bonventre JV. Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery. J Clin Invest 1995; 95: 1062-1070
15. Itoh F, Kaji T, Hayakawa Y, Oguma Y, Sakuragawa N. Heparin enhances thrombin-stimulated prostaglandin I2 production by cultured endothelial cells. Thromb Res 1990; 57: 481-488
16. Upchurch GR Jr, Welch GN, Freedman JE, Fabian AJ, Pigazzi A, Scribner AM, Alpert CS, Keaney JF Jr, Loscalzo J. High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells. Circulation 1997; 95: 2115-2121
17. Boitano S, Dirksen ER, Sanderson MJ. Intercellular propagation of calcium waves mediated by inositol trisphosphate. Science 1992; 258: 292-295